Damora Therapeutics (DMRA) Operating Expenses (2019 - 2026)
Damora Therapeutics (DMRA) posted Operating Expenses of $30.8 million for Q1 2026, down 84.72% on a QoQ basis from $201.7 million in Q4 2025, and up 1085.49% year-over-year from $2.6 million in Q1 2025.
Damora Therapeutics (DMRA) Operating Expenses (2019 - 2026) Analysis & Trends
Damora Therapeutics' Operating Expenses history runs 8 years deep, the most recent figure standing at $30.8 million for Q1 2026.
- Quarterly Operating Expenses rose 1085.49% year-over-year to $30.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $239.1 million (up 1150.57% YoY) and the FY2025 annual result came in at $210.9 million, up 847.31% from the prior year.
- Operating Expenses was $30.8 million for Q1 2026 at Damora Therapeutics, down from $201.7 million in the prior quarter.
- Across five years, Operating Expenses topped out at $201.7 million in Q4 2025 and bottomed at $2.6 million in Q1 2025.
- A 5-year average of $21.5 million and a median of $8.6 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2024 — Operating Expenses sank 57.45% — and 2025, when it surged 2739.99%.
- Damora Therapeutics' Operating Expenses stood at $13.5 million in 2022, then sank by 50.68% to $6.7 million in 2023, then gained by 6.46% to $7.1 million in 2024, then jumped by 2739.99% to $201.7 million in 2025, then tumbled by 84.72% to $30.8 million in 2026.
- Business Quant data shows DMRA's Operating Expenses at $30.8 million in Q1 2026, $201.7 million in Q4 2025, and $3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - | 30.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.81 Mn |
| Dec 31, 2025 | 201.70 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 3.42 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 7.10 Mn |
| Sep 30, 2024 | 3.84 Mn |
| Jun 30, 2024 | 5.58 Mn |
| Mar 31, 2024 | 5.74 Mn |
| Dec 31, 2023 | 6.67 Mn |
| Sep 30, 2023 | 8.58 Mn |
| Jun 30, 2023 | 11.16 Mn |
| Mar 31, 2023 | 13.49 Mn |
| Dec 31, 2022 | 13.53 Mn |
| Sep 30, 2022 | 13.62 Mn |
| Jun 30, 2022 | 17.12 Mn |
| Mar 31, 2022 | 16.94 Mn |
| Dec 31, 2021 | 13.47 Mn |
| Sep 30, 2021 | 12.94 Mn |
| Jun 30, 2021 | 12.27 Mn |